Solid Organ Transplant Immunosuppressant Market to 2018 - Limited Availability of Donors Drives Improvements in Organ Procurement and Preservation Methods - GBI Research Reports

Solid Organ Transplant Immunosuppressant Market to 2018 - Limited Availability of Donors Drives Improvements in Organ Procurement and Preservation Methods

Solid Organ Transplant Immunosuppressant Market to 2018 - Limited Availability of Donors Drives Improvements in Organ Procurement and Preservation Methods - GBI Research Reports
Solid Organ Transplant Immunosuppressant Market to 2018 - Limited Availability of Donors Drives Improvements in Organ Procurement and Preservation Methods
Published Jan 16, 2012
87 pages — Published Jan 16, 2012
Price US$ 3,500.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

GBI Research, the leading business intelligence provider, has released its latest research, Solid Organ Transplant Immunosuppressant Market to 2018 - Limited Availability of Donors Drives Improvements in Organ Procurement and Preservation Methods, which provides insight into the global solid organ transplant immunosuppressant drug market until 2018. The report provides an in-depth analysis of the following five transplant areas: heart, lung, pancreas, liver and kidney. It also details immunosuppressant drug markets in the following key regions: the US, the top five countries of Europe and Japan. The report also includes details about immunosuppressant drug R&D pipelines.

The report is built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis by GBI Researchs team of industry experts.

GBI Research analysis shows that the global market for immunosuppressant drugs used in transplants is projected to increase at a compound annual growth rate (CAGR) of 6.7% from 20042010. The market is forecast to grow at a CAGR of 6.1% from 20102018, to reach a value of $5.6 billion in 2018. GBI Research analysis found the R&D pipeline for the immunosuppressant drug market to be moderate. The leading companies in this market, F. Hoffman La Roche, Novartis AG, Genzyme Corporation and Astellas Pharma Inc., are also analyzed in this report.

Scope

- Analysis of the five major solid organ immunosuppressant drugs market which include heart transplant, pancreas transplant, lung transplant, kidney transplant and liver transplant immunosuppressant drug market
- Data and analysis of the immunosuppressant drug market in the leading regions of the world: the US, the top five countries of Europe and Japan.
- Annualized market data for the immunosuppressant drug market from 20042010, with forecasts to 2018.
- Market data on the geographical landscape and therapeutic landscape, including market sizes, market shares, annual costs of therapy and target populations.
- Key drivers and restraints that have had a significant impact on the market.
- Pipeline analysis of the immunosuppressant drug market for the five types of transplant.
- Competitive landscape of the global immunosuppressant drug market including benchmarking of top companies. The key companies studied in this report are: F. Hoffman La Roche, Novartis AG, Genzyme Corporation and Astellas Pharma Inc.

Reasons to buy

- The report will aid business development and help marketing executives strategize product launches, and
- Build effective strategies to launch pipeline products by identifying potential geographies.
- Develop key strategic initiatives by studying the key strategies of top competitors.
- Develop market entry and market expansion strategies by identifying geographic markets poised for strong growth.
- Reinforce R&D pipelines by identifying new target mechanisms which can produce first in class molecules with better efficacy and safety.

  
Source:
Document ID
GBIHC185MR
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents38
  List of Tables63
  List of Figures92
Solid Organ Transplant Immunosuppressant Market to 2018 - Introduction111
  Overview111
  GBI Research Report Guidance111
Solid Organ Transplant Immunosuppressant Market to 2018 - Market Overview1210
  Introduction121
    Types of Transplant121
      Autograft121
      Allograft121
      Isograft121
      Xenograft121
    Transplant Rejection131
      Hyperacute Rejection131
      Acute Rejection131
      Chronic Rejection131
    Immunosuppressive Drug Therapy131
      Classification of Immunosuppressant Drugs131
      Immunosuppressant Drug Therapy Monitoring141
  Market Forecast151
    Market Share by Disease Sector161
    Market Share by Geography171
  Annual Cost of Therapy181
  Target Population191
  Solid Organ Transplant Immunosuppressant Market Drivers and Restraints201
    Drivers201
      Improved Organ Preservation Techniques, Immunosuppressive Therapy and Advanced Surgical Techniques201
      Better Understanding of Immunological Mechanisms201
    Restraints211
      Ethical and Philosophical Barriers211
      Lack of Knowledge Regarding Organ Transplants amongst Prospective Donors211
Solid Organ Transplant Immunosuppressant Market to 2018 - Geographical Landscape2211
  The US221
    Introduction221
    Revenue221
    Annual Cost of Therapy231
    Target Population241
  Top Five Countries of Europe251
    Introduction251
    Revenue252
    Annual Cost of Therapy271
    Target Population281
  Japan291
    Introduction291
    Revenue291
    Annual Cost of Therapy301
    Target Population312
Solid Organ Transplant Immunosuppressant Market to 2018 - Therapeutic Landscape3318
  Heart Transplant Market331
    Introduction331
    Revenue331
    Annual Cost of Therapy341
    Target Population351
  Lung Transplant Market361
    Introduction361
    Revenue362
    Annual Cost of Therapy381
    Target Population391
  Kidney Transplant Market401
    Introduction401
    Revenue401
    Annual Cost of Therapy411
    Target Population421
  Liver Transplant Market431
    Introduction431
    Revenue432
    Annual Cost of Therapy451
    Target Population461
  Pancreas Transplant Market471
    Introduction471
    Revenue472
    Annual Cost of Therapy491
    Target Population501
Solid Organ Transplant Immunosuppressant Market to 2018 - Product Pipeline Analysis5113
  Research and Development (R&D) Pipeline by Indication511
  R&D Pipeline by Phase521
  R&D Pipeline - Heart Transplant531
    Overview531
    Pre-Clinical Phase541
    Phase II541
    Phase III541
  R&D Pipeline - Lung Transplant551
    Overview551
    Pre-Clinical Phase561
    Phase II561
    Phase III561
  R&D Pipeline - Kidney Transplant571
    Overview571
    Pre-Clinical Phase581
    Phase I581
    Phase II581
    Phase III591
  R&D Pipeline - Liver Transplant601
    Overview601
    Pre-Clinical Phase601
    Phase II611
    Phase I611
    Pre-Clinical Phase611
  R&D Pipeline - Pancreas Transplant621
    Overview621
    Phase II631
    Phase III631
Solid Organ Transplant Immunosuppressant Market to 2018 - Marketed Products645
  Prograf641
    Overview641
    Safety641
    Efficacy641
      Liver Transplantation641
      Kidney Transplantation651
  Cellcept651
    Overview651
    Safety651
    Efficacy651
      Renal Transplant651
      Cardiac Transplant661
      Hepatic Transplant661
      Results661
  Myfortic661
    Overview661
    Safety661
    Efficacy671
  Neoral671
    Overview671
    Safety671
    Efficacy671
  Zenapax681
    Overview681
    Safety681
    Efficacy681
Solid Organ Transplant Immunosuppressant Market to 2018 - Competitive Landscape696
  F. Hoffman La Roche691
    Overview691
    Marketed Products691
    SWOT Analysis701
  Novartis AG711
    Overview711
    Marketed Products711
    SWOT Analysis721
  Genzyme Corporation721
    Overview721
    Marketed Products721
    SWOT Analysis731
  Astellas Pharma Inc.731
    Overview731
    Marketed Products731
    SWOT Analysis741
Solid Organ Transplant Immunosuppressant Market to 2018 - Strategic Consolidations757
  Segmentation by Type751
  Segmentation by Year761
  Segmentation by Indication771
  Segmentation by Geography781
  Segmentation by Deal Value791
  Major M&As801
  Major Licensing Agreements801
  Major Co-Development Deals811
Solid Organ Transplant Immunosuppressant Market to 2018 -Appendix826
  Market Definitions821
  Abbreviations821
  Research Methodology825
    Coverage821
    Secondary Research831
    Primary Research831
    Therapeutic Landscape831
      Epidemiology-based Forecasting841
    Market Size by Geography851
    Geographical Landscape861
    Pipeline Analysis861
    Competitive Landscape861
    Expert Panel Validation861
  Contact Us861
  Disclaimer861
  Sources871

Table Of Contents

GBI Research Reports—GBI Research covers worldwide markets and issues, supplies actionable data and forecasts and is driven by industry leaders' insights. GBI Research provides a broad spectrum of reports across the healthcare and energy industries and its online offering is easy to navigate - a comprehensive resource for business information needs.

About the Author


Cite this Report

  
MLA:
GBI Research Reports. "Solid Organ Transplant Immunosuppressant Market to 2018 - Limited Availability of Donors Drives Improvements in Organ Procurement and Preservation Methods" Jan 16, 2012. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GBI-Research-Reports/Solid-Organ-Transplant-Immunosuppressant-Market-to-2018-Limited-Availability-of-Donors-Drives-Improvements-in-Organ-Procurement-and-Preservation-Methods-2115-344>
  
APA:
GBI Research Reports. (2012). Solid Organ Transplant Immunosuppressant Market to 2018 - Limited Availability of Donors Drives Improvements in Organ Procurement and Preservation Methods Jan 16, 2012. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GBI-Research-Reports/Solid-Organ-Transplant-Immunosuppressant-Market-to-2018-Limited-Availability-of-Donors-Drives-Improvements-in-Organ-Procurement-and-Preservation-Methods-2115-344>
  
US$ 3,500.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.